Skip to content

Beta Bionics, Inc. Common Stock BBNX Balance Sheet Statement

TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
$30.21M-28.9%$31.58M+3.8%$38.49M+120%$35.08M$42.45M
$169.31M$187.55M$190.2M
$55.8M$49.11M$43.99M
$83.15M+125%$75.15M+219%$66.75M+482%$50.3M+541%$36.87M+769%
$247.99M$267.91M$270.03M
$10.16M$8.6M$7.39M
$304.42M$328.74M$330.05M
$15.2M+103%$16.34M+269%$14.19M+418%$9.84M+249%$7.47M+286%
$3.35M$3.3M$2.99M
$23.19M$30.92M$25.39M
$33.17M$41.13M$35.29M
$5K$4K$4K
-$391.83M-$369.94M-$356.47M
$271.25M-13.5%$287.61M+217%$294.76M+229%$301.63M$313.75M
$304.42M$328.74M$330.05M

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Beta Bionics, Inc. Common Stock's total assets?
Beta Bionics, Inc. Common Stock (BBNX) holds $304.4M in total assets, down 9.9% year over year.
How much debt does Beta Bionics, Inc. Common Stock have?
Beta Bionics, Inc. Common Stock carries $6.9M in total debt against $271.2M of shareholders' equity, a debt-to-equity ratio of 0.03.
How much cash does Beta Bionics, Inc. Common Stock have?
Beta Bionics, Inc. Common Stock holds $30.2M in cash and equivalents.
Can Beta Bionics, Inc. Common Stock cover its short-term obligations?
Its current ratio is 10.69 — current assets exceed current liabilities.
Where does Beta Bionics, Inc. Common Stock's balance sheet data come from?
Every line is extracted from Beta Bionics, Inc. Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.